Amylyx Pharmaceuticals Inc (AMLX) Gets a Buy from LifeSci CapitalTip Ranks·2 days ago, 02:35 PMAMLX-1.32%
Eton Pharma Chief Business Officer David Krempa reports disposal of 25,000 common shares valued at $1.63 millionPUBT·9 hours agoETON+1.51%
NewEdge Advisors LLC Grows Stake in Corcept Therapeutics Incorporated $CORTMarket Beat·22 hours agoCORT+0.81%STT+2.03%
Amylyx Pharmaceuticals Prices 14.09M-Share Public Offering at $35.50; Nets ~$472MTradingView·Aug 20 at 04:33 PMAMLX-1.32%
Amylyx Pharmaceuticals Announces Pricing of an Upsized $500 Million Underwritten Public Offering of Common Stock | AMLX Stock NewsStockTitan·Aug 19 at 02:06 PMAMLX-1.32%
39,241 Shares in Amylyx Pharmaceuticals, Inc. $AMLX Bought by GSA Capital Partners LLPMarket Beat·Aug 20 at 02:44 AMAMLX-1.32%
Eton Pharmaceuticals Chief Business Officer Sold Shares Worth Over $1.6MTradingView·9 hours agoETON+1.51%
AMLX Stock Soars as Amylyx GLP-1 Drug Succeeds in Late-Stage TrialBarchart Option·Aug 18 at 03:13 PMAMLX-1.32%
Crinetics supplements proxy disclosures for Vertex USD 85-per-share buyout after shareholder suitsPUBT·Aug 19 at 03:08 PMCRNX+0.11%VRTX-0.08%
Amylyx Pharmaceuticals Stock Climbs 50% Over Positive Topline Data From Phase 3 LUCIDITY Trialrttnews·Aug 18 at 10:20 AMAMLX-1.32%
Amylyx Pharmaceuticals Comes Closer to Potentially Delivering First Treatment for Weight Loss Surgery-Related Low Suger Levelbenzinga_article·Aug 18 at 08:26 AMAMLX-1.32%
AMLX: Avexitide achieved a 55% reduction in severe hypoglycemic events in PBH, with strong safety dataQuartr·Aug 18 at 08:06 AMAMLX-1.32%
Biotech Stocks At 52-Week Highs - ELOX, PRLD, ARGX, BOLD, CORTrttnews·20 hours agoPRLD-2.41%BOLD-1.33%
Corcept Therapeutics director David L. Mahoney sells 103,606 shares worth $12.26 millionPUBT·Aug 20 at 03:30 PMCORT+0.81%
Amylyx Pharmaceuticals Announces $350.0 Million Proposed Public Offering of Common Stock | AMLX Stock NewsStockTitan·Aug 18 at 07:01 AMAMLX-1.32%MS-0.06%
